Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1891 AL 1905

Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology

Fanciulli A, Sixel-Döring F, Buhmann C, Krismer F, Hermann W, Winkler C, Woitalla D, Jost WH; German Parkinson’s Guideline Group; Trenkwalder C, Höglinger G.

J Neurol. 2025 Jan 3;272(1):90. doi: 10.1007/s00415-024-12730-5.

Associations between frailty and cognitive impairment in Parkinson´s disease: a cross-sectional study

Sousa-Fraguas MC, Rodríguez-Fuentes G, Lastra-Barreira D, Conejo NM.

Aging Clin Exp Res. 2025 Jan 3;37(1):19. doi: 10.1007/s40520-024-02922-4.

A rare variant in the UQCRC1 gene, p.(Gly405Val) in three Austrian Parkinson's patients

Brücke C, Brücke T, Pirker W, Zimprich A.

Parkinsonism Relat Disord. 2025 Feb;131:107250. doi: 10.1016/j.parkreldis.2024.107250. Epub 2024 Dec 21.

Patterns of neuronal synchrony in higher-order networks

Majhi S, Ghosh S, Pal PK, Pal S, Pal TK, Ghosh D, Završnik J, Perc M.

Phys Life Rev. 2025 Mar;52:144-170. doi: 10.1016/j.plrev.2024.12.013. Epub 2024 Dec 30.

Space exploration and risk of Parkinson's disease: a perspective review

Ali N, Beheshti A, Hampikian G.

NPJ Microgravity. 2025 Jan 3;11(1):1. doi: 10.1038/s41526-024-00457-6.

A Wonderful Journey: The Diverse Roles of Adenosine Deaminase Action on RNA 1 (ADAR1) in Central Nervous System Diseases

Cheng L, Liu Z, Shen C, Xiong Y, Shin SY, Hwang Y, Yang SB, Chen Z, Zhang X.

CNS Neurosci Ther. 2025 Jan;31(1):e70208. doi: 10.1111/cns.70208.

Exploring the stigma experienced by people affected by Parkinson's disease: a systematic review

Crooks S, Mitchell G, Wynne L, Carter G.

BMC Public Health. 2025 Jan 3;25(1):25. doi: 10.1186/s12889-024-21236-8.

Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases

Xu L, Li C, Wan T, Sun X, Lin X, Yan D, Li J, Wei P.

Cell Commun Signal. 2025 Jan 3;23(1):4. doi: 10.1186/s12964-024-01965-4.

The Intricate Interplay: Microbial Metabolites and the Gut-Liver-Brain Axis in Parkinson's Disease

Kollaparampil Kishanchand D, K A AK, Chandrababu K, Philips CA, Sivan U, Pulikaparambil Sasidharan BC.

J Neurosci Res. 2025 Jan;103(1):e70016. doi: 10.1002/jnr.70016.

Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors

Liu S, Liu T, Li J, Hong J, Moosavi-Movahedi AA, Wei J.

Neurosci Bull. 2025 Apr;41(4):676-690. doi: 10.1007/s12264-024-01342-8. Epub 2025 Jan 4.

Drug repositioning for Parkinson's disease: An emphasis on artificial intelligence approaches

Karimi-Sani I, Sharifi M, Abolpour N, Lotfi M, Atapour A, Takhshid MA, Sahebkar A.

Ageing Res Rev. 2025 Feb;104:102651. doi: 10.1016/j.arr.2024.102651. Epub 2025 Jan 2.

Harmonious ageing: a narrative review of music therapy in the biomedical literature

Raja S, Barry C, Upadhyay R, Alash R, O'Raghallaigh M, Hayes R, Romero-Ortuno R.

Eur Geriatr Med. 2025 Apr;16(2):461-472. doi: 10.1007/s41999-024-01146-z. Epub 2025 Jan 4.

Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis

Jiang M, Chi J, Qiao Y, Wang J, Zhang Z, Liu J, Sheng X, Yuan L.

Pharmacol Res. 2025 Feb;212:107578. doi: 10.1016/j.phrs.2025.107578. Epub 2025 Jan 3.

Plexins: Navigating through the neural regulation and brain pathology

Khan A, Sharma P, Dahiya S, Sharma B.

Neurosci Biobehav Rev. 2025 Feb;169:105999. doi: 10.1016/j.neubiorev.2024.105999. Epub 2025 Jan 3.

Positron emission tomography tracers for synucleinopathies

Xiang J, Zhang Z, Wu S, Ye K.

Mol Neurodegener. 2025 Jan 5;20(1):1. doi: 10.1186/s13024-024-00787-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias